Cyclic nucleotide phosphodiesterases (PDEs) hydrolyze cAMP or cGMP and terminate their signaling. Two important families of PDEs that regulate cAMP signaling in cardiovascular tissues are the cGMP-inhibited PDEs (PDE3) and the cAMP-specific PDEs (PDE4). In this study, we have used a combination of an in vitro motility assay and a sensitive method for the measurement of cAMP in order to determine the relative roles of PDE3 and of PDE4 in the regulation of cAMP-mediated inhibition of VSMC migration. Our data demonstrate that forskolin, an activator of adenylyl cyclases, causes concentration-dependent inhibition of platelet-derived growth factor-induced VSMC migration. Incubation of cultured VSMCs with a PDE4-selective inhibitor, Ro 20-1724, markedly potentiated both the antimigratory effect and the increase in cAMP caused by forskolin. Cilostamide, a PDE3-selective compound, did not affect either the antimigratory activity of forskolin or its ability to increase cAMP. Cilostamide and Ro 20-1724 interacted synergistically to potentiate the inhibition of VSMC migration by forskolin and caused a supra-additive increase in cAMP. These data are consistent with an important role for both PDE3 and PDE4 in the regulation of cAMP-mediated inhibition of VSMC migration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1161/01.res.82.8.852 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Magnolia kobus DC. suppresses neointimal hyperplasia by regulating ferroptosis and VSMC phenotypic switching in a carotid artery ligation mouse model.
Chin Med
January 2025
Aging and Metabolism Research Group, Korea Food Research Institute, Wanju‑gun, 55365, Republic of Korea.
Background: Magnolia kobus DC (MO), as a plant medicine, has been reported to have various physiological activities, including neuroprotective, anti-inflammatory, and anti-diabetic effects. However, vascular protective effects of MO remain incompletely understood. In this study, we evaluated the vascular protective effect of MO against ferroptosis in a carotid artery ligation (CAL)-induced neointimal hyperplasia mouse model and in aortic thoracic smooth muscle A7r5 cells.
View Article and Find Full Text PDFVSMC-specific TRPC1 deletion attenuates angiotensin II-induced hypertension and cardiovascular remodeling.
J Mol Med (Berl)
January 2025
Wuxi School of Medicine, Jiangnan University, Jiangsu Province, 1800 Lihu Rd, Wuxi, 214122, China.
Article Synopsis
- TRPC1 is a ion channel linked to cardiovascular issues, with increased expression observed in both treated vascular smooth muscle cells (VSMCs) and aortas of hypertensive mice.
- Lack of TRPC1 in VSMCs significantly reduces AngII-induced effects like vasoconstriction, hypertension, and heart changes, indicating its crucial role in these processes.
- The study identifies the EZH2-TRPC1-MEK/ERK pathway as a significant contributor to hypertension, suggesting that targeting TRPC1 or EZH2 could be effective in treating high blood pressure and related cardiovascular problems.
Nuclear receptor subfamily 4 group a member 1 eases angiotensin II-arose oxidative stress in vascular smooth muscle cell by boosting nucleotide-binding oligomerization domain-like receptor family caspase recruitment domain containing 3 transcription.
Cytojournal
November 2024
The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Objective: Hypertension significantly contributes to morbidity and mortality. Nuclear receptor subfamily 4 group a member 1 (Nur77) participates in regulating oxidative stress, but the mechanism in hypertension remains unclear. This study aimed to explore the function of Nur77 in oxidative stress induced by Angiotensin II (Ang II) in vascular smooth muscle cells (VSMCs) in hypertension.
View Article and Find Full Text PDFFunctional screening identifies miRNAs with a novel function inhibiting vascular smooth muscle cell proliferation.
Mol Ther
December 2024
Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, EH16 4TJ Edinburgh, UK; CARIM School for Cardiovascular Sciences, Department of Pathology, Maastricht University Medical Center (MUMC), 6229HX Maastricht, the Netherlands. Electronic address:
Article Synopsis
- The study identifies seven microRNAs (miRNAs) that inhibit the proliferation of vascular smooth muscle cells (vSMCs), important in preventing vascular remodeling issues.
- Through high-throughput screening of 2,042 human miRNA mimics, the researchers pinpointed miR-323a-3p, miR-449b-5p, miR-491-3p, miR-892b, miR-1827, miR-4774-3p, and miR-5681b as effective in reducing vSMC proliferation.
- The findings suggest these miRNAs could be developed into therapeutic agents, particularly for conditions like vein graft failure, showing minimal toxicity and altering key cell-cycle gene networks involved in
Nox1/PAK1 is required for angiotensin II-induced vascular inflammation and abdominal aortic aneurysm formation.
Redox Biol
February 2025
Department of Biochemistry and Molecular Biology, School of Basic Medicine, Guizhou Medical University, Gui'an, 561113, Guizhou, PR China. Electronic address:
NADPH oxidase 1 (Nox1) is a major isoform of Nox in vascular smooth muscle cells (VSMCs). VSMC activation and extracellular matrix (ECM) remodelling induce abdominal aortic aneurysm (AAA). In this study, we aim to determine the role of Nox1 in the progression of AAA and explore the underling mechanism.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!